Detalhe da pesquisa
1.
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.
Haematologica
; 106(8): 2114-2120, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646891
2.
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.
Blood
; 137(4): 569-572, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507294
3.
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
Am J Hematol
; 90(4): 295-300, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545153
4.
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.
Haematologica
; 99(1): 54-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142996
5.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409798
6.
Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia.
Clin Adv Hematol Oncol
; 11(9): 571-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24518520
7.
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.
Haematologica
; 96(6): 914-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21393334
8.
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
J Clin Invest
; 130(10): 5127-5141, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831296
9.
Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood Adv
; 4(4): 611-616, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32074276
10.
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.
Leukemia
; 32(11): 2352-2362, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720734
11.
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies.
Leukemia
; 36(4): 1164-1166, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058596
12.
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML).
Leuk Lymphoma
; 62(6): 1532-1535, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752557
13.
Need for routine examination of left ventricular ejection fraction in patients with AML.
Leukemia
; 34(4): 1169-1171, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719680
14.
Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
JAMA Oncol
; 1(8): 1120-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355382
15.
Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 19(12): e633-e635, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648955
16.
Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML).
Leuk Res Rep
; 2(1): 26-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371771
17.
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study.
Leuk Lymphoma
; 54(11): 2534-6, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432687